ABSTRACT
South Asian women are at increased risk of developing gestational diabetes (GDM). Few studies have investigated the genetic contributions to GDM risk. We investigated the association of a type 2 diabetes (T2D) polygenic risk score (PRS), on its own, and with GDM risk factors, on GDM-related traits using data from two birth cohorts in which South Asian women were enrolled during pregnancy. 837 and 4,372 pregnant South Asian women from the SouTh Asian BiRth CohorT (START) and Born in Bradford (BiB) cohort studies underwent a 75-gram glucose tolerance test. PRSs were derived using GWAS results from an independent multi-ethnic study (∼18% South Asians). Associations with fasting plasma glucose (FPG); 2h post-load glucose (2hG); area under the curve glucose; and GDM were tested using linear and logistic regressions. The population attributable fraction (PAF) of the PRS was calculated. Every 1 SD increase in the PRS was associated with a 0.085 mmol/L increase in FPG ([95%CI=0.07-0.10], P=2.85 × 10−20); 0.21 mmol/L increase in 2hG ([95%CI=0.16-0.26], P=5.49 × 10−16); and a 45% increase in the risk of GDM ([95%CI=32-60%], P=2.27 × 10−14), independent of parental history of diabetes and other GDM risk factors. PRS tertile 3 accounted for 12.5% of the population’s GDM. No consistent interactions of the PRS with BMI, or diet quality were observed. A T2D PRS is strongly associated with multiple GDM-related traits in women of South Asian descent, and accounts for a substantial proportion of the PAF of GDM.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Studies: The South Asian Birth Cohort (START) study data were collected as part of a program funded by the Indian Council of Medical Research and in Canada by the Canadian Institutes of Health Research (grant INC-109205), and the Heart and Stroke Foundation (grant NA7283) with founding principal investigators: Sonia S Anand, Anil Vasudevan, Milan Gupta, Katherine Morrison, Anura Kurpad, Koon K Teo, and Krishnamachari Srinivasan. The Born in Bradford (BiB) The Born in Bradford cohort is funded by the National Institute for Health Research Collaboration for Applied Health Research and Care (NIHR CLAHRC) and the Programme Grants for Applied Research funding scheme (RP-PG-0407-10044). The study also receives funding from the Wellcome Trust (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (ESRC) (MR/N024397/1) and the British Heart Foundation (CS/16/4/32482). DNA extraction was funded by the UK Medical Research Council via the Integrative Epidemiology Unit (MRC IEU; MC_UU_12013/5) and genotyping via the MRC IEU and a National Institute of Health Research Senior Investigator Award to D.A.L. (NF-0616-10102). Authors: Research associate (A.L.) and graduate student (J.L.) costs were covered by two Canadian Institutes of Health Research Grants [Project grant number: 298104, Foundation Scheme grant number: FDN-143255, Study grant numbers: INC 109205, NA 7283] awarded to S.S.A; D.A.L's contribution to this study is supported by the Bristol NIHR Biomedical Research Centre, the UK Medical Research Council (MC_UU_00011/6) and the British Heart Foundation (CH/F/20/90003). S.S.A. is supported by a Tier 1 Canada Research Chain in Ethnic Diversity and Cardiovascular Disease, and a Heart and Stroke Foundation/Michael G. DeGroote Chair in Population Health Research at McMaster University. Competing/Duality of interests: DAL has received support from Medtronic Ltd and Roche Diagnostics for research unrelated to that presented here. No financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Other than those declared by DAL above, no authors have any duality of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The START study was approved by local ethics committees (Hamilton Integrated Research Ethics Board [ID:10-640], William Osler Health System [ID:11-0001], and Trillium Health Partners [RCC:11-018, ID:492]). Ethical approval for all aspects of the research in the Born in Bradford study was granted by Bradford Research Ethics Committee [Ref 07/H1302/112].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
: SSA, and JW hold the generated/analyzed START and BiB data used in this study respectively. The Data from START contains identifiable information that cannot be given to an outside group and is not publicly available as per the study's ethics guidelines. Nevertheless, requests for collaboration will be considered. Access to de-identified BiB data can be requested by following the instructions detailed here: https://borninbradford.nhs.uk/research/how-to-access-data/.
ABBREVIATIONS
- 1KG
- 1000 Genomes
- 2hG
- 2h post-load Glucose
- AF
- Attributable Fraction
- AUC
- Area Under the Curve
- AUCg
- AUC glucose
- BiB
- Born in Bradford
- CI
- Confidence Interval
- DIAGRAM
- DIAbetes Genetics Replication and Meta-analysis
- DNA
- DeoxyriboNucleic Acid
- FFQ
- Food Frequency Questionnaire
- FPG
- Fasting Plasma Glucose
- GCSE
- General Certificate of Secondary Education
- GDM
- Gestational Diabetes Mellitus
- GWAS
- Genome-Wide Association Study
- IADPSG
- International Association of Diabetes and Pregnancy Study Groups
- OR
- Odds Ratio
- PAF
- Population Attributable Fraction
- PRS
- Polygenic Risk Score
- SE
- Standard Error
- START
- SouTh Asian biRth cohort
- T2D
- Type 2 Diabetes
- UK
- United Kingdom
